TY - CONF T1 - Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. T2 - Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications Y1 - 2001 A1 - Jussila, L. A1 - Veikkola, T. A1 - Jeltsch, M. A1 - Thurston, G. A1 - McDonald, D. A1 - Achen, M. A1 - Stacker, S. A1 - Alitalo, K. JF - Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications CY - Miami Beach, Florida ER -